T&W Medical A/S financials

T&W Medical A/S

Country: DK Reporting currency: DKK Latest annual report: 2025-09-30

LEI: 984500981D136F0C7018

Financial statements (DKK, as reported — unscaled; 113 line items across 3 annual periods)

Line item	2025	2024	2023
Income statement
Revenue	DKK 19.25B	DKK 19.67B	—
Gross profit	DKK 12.09B	DKK 11.15B	—
Operating profit (EBIT)	DKK 1.91B	-DKK 7.59B	—
Net finance income / (cost)	-DKK 1.85B	-DKK 3.35B	—
Profit before tax	DKK 60.0M	-DKK 10.94B	—
Income tax expense	DKK 407.0M	-DKK 1.81B	—
Profit for the year	-DKK 347.0M	-DKK 9.13B	—
— attributable to owners	-DKK 536.0M	-DKK 4.77B	—
— attributable to NCI	DKK 189.0M	-DKK 4.36B	—
Total comprehensive income	-DKK 592.0M	-DKK 9.49B	—
Cash flow statement
Cash generated from operations	DKK 2.95B	DKK 2.15B	—
Net cash from operating activities	DKK 2.82B	DKK 2.02B	—
Net cash from investing activities	-DKK 887.0M	DKK 996.0M	—
Net cash from financing activities	-DKK 2.89B	-DKK 2.12B	—
Dividends paid	DKK 655.0M	DKK 37.0M	—
Proceeds from borrowings	DKK 1.87B	DKK 28.83B	—
Repayments of borrowings	DKK 4.69B	DKK 31.64B	—
Lease liability payments	DKK 366.0M	DKK 345.0M	—
Net change in cash	-DKK 951.0M	DKK 904.0M	—
Balance sheet
Total assets	DKK 42.04B	DKK 43.05B	DKK 54.01B
Non-current assets	DKK 35.52B	DKK 35.88B	DKK 47.19B
Property, plant & equipment	DKK 2.03B	DKK 2.14B	DKK 2.20B
Right-of-use assets	DKK 935.0M	DKK 1.01B	DKK 962.0M
Intangible assets & goodwill	DKK 26.73B	DKK 26.81B	DKK 26.97B
Current assets	DKK 6.52B	DKK 7.17B	DKK 6.83B
Inventories	DKK 1.63B	DKK 1.69B	DKK 1.55B
Trade & other receivables	DKK 2.44B	DKK 2.36B	DKK 2.25B
Cash & equivalents	DKK 816.0M	DKK 1.80B	DKK 967.0M
Total equity	DKK 9.98B	DKK 6.98B	DKK 12.76B
— attributable to owners	DKK 739.0M	DKK 1.30B	DKK 5.07B
Non-controlling interests	DKK 9.24B	DKK 5.67B	DKK 7.69B
Non-current liabilities	DKK 25.71B	DKK 28.66B	DKK 33.45B
Long-term borrowings	DKK 23.39B	DKK 26.57B	DKK 29.20B
Lease liabilities (non-current)	DKK 815.0M	DKK 846.0M	DKK 815.0M
Current liabilities	DKK 6.35B	DKK 7.41B	DKK 7.80B
Short-term borrowings	DKK 1.17B	DKK 658.0M	DKK 928.0M
Lease liabilities (current)	DKK 307.0M	DKK 312.0M	DKK 296.0M
Deferred tax liabilities	DKK 37.0M	DKK 45.0M	DKK 2.41B
Derived metrics
Operating margin	9.9%	-38.6%	—
Net margin	-1.8%	-46.4%	—
Return on equity	-3.5%	-130.8%	—
Cash conversion ratio	-8.14×	-0.22×	—
Other reported items
Adjustments For Decrease Increase In Inventories	DKK 61.0M	-DKK 136.0M	—
Adjustments For Decrease Increase In Other Current Assets	-DKK 299.0M	-DKK 213.0M	—
Adjustments For Decrease Increase In Trade Account Receivable	-DKK 85.0M	-DKK 28.0M	—
Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss	DKK 1.08B	DKK 10.48B	—
Adjustments For Income Tax Expense	DKK 407.0M	-DKK 1.81B	—
Adjustments For Increase Decrease In Trade Account Payable	DKK 73.0M	DKK 7.0M	—
Adjustments For Losses Gains On Disposal of Noncurrent Assets	DKK 7.0M	-DKK 7.0M	—
Adjustments For Provisions	-DKK 103.0M	DKK 82.0M	—
Adjustments For Undistributed Profits of Associates	DKK 16.0M	-DKK 6.0M	—
Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method	-DKK 68.0M	DKK 41.0M	—
Cash Flows From Used In Operations Before Changes In Working Capital	DKK 3.16B	DKK 2.51B	—
Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities	DKK 13.0M	-DKK 15.0M	—
Comprehensive Income Attributable To Noncontrolling Interests	-DKK 147.0M	-DKK 188.0M	—
Cost of Merchandise Sold	DKK 7.16B	DKK 8.52B	—
Current Loans and Receivables	DKK 97.0M	DKK 119.0M	DKK 119.0M
Current Prepayments	DKK 2.0M	DKK 1.0M	DKK 2.0M
Current Tax Assets Current	DKK 0	DKK 34.0M	DKK 113.0M
Current Tax Liabilities Current	DKK 366.0M	DKK 241.0M	DKK 186.0M
Deferred Tax Assets	DKK 787.0M	DKK 758.0M	DKK 768.0M
Dividends Paid To Equity Holders of Parent Classified As Financing Activities	DKK 655.0M	DKK 37.0M	—
Effect of Exchange Rate Changes On Cash and Cash Equivalents	-DKK 37.0M	-DKK 67.0M	—
Equity and Liabilities	DKK 42.04B	DKK 43.05B	DKK 54.01B
Finance Income Received Classified As Operating Activities	DKK 178.0M	DKK 156.0M	—
Gains Losses On Cash Flow Hedges Before Tax	-DKK 60.0M	-DKK 486.0M	—
Income Tax Relating To Components of Other Comprehensive Income	-DKK 2.0M	-DKK 96.0M	—
Income Tax Relating To Components of Other Comprehensive Income That Will Be Reclassified To Profit Or Loss	-DKK 5.0M	-DKK 99.0M	—
Income Tax Relating To Components of Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss	DKK 3.0M	DKK 3.0M	—
Income Taxes Paid Refund Classified As Operating Activities	DKK 306.0M	DKK 284.0M	—
Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control	-DKK 25.0M	DKK 0	—
Increase Decrease Through Other Contributions By Owners	DKK 4.26B	DKK 3.82B	—
Increase Decrease Through Transfers and Other Changes Equity	DKK 16.0M	-DKK 67.0M	—
Intangible Assets Other Than Goodwill	DKK 1.38B	DKK 1.30B	DKK 10.73B
Interest Expense	DKK 2.43B	DKK 3.67B	—
Interest Paid Classified As Financing Activities	DKK 2.26B	DKK 2.28B	—
Investments In Associates Accounted For Using Equity Method	DKK 327.0M	DKK 218.0M	DKK 273.0M
Issued Capital	DKK 564.0M	DKK 564.0M	DKK 564.0M
Liabilities	DKK 32.06B	DKK 36.07B	DKK 41.26B
Noncurrent Loans and Receivables	DKK 433.0M	DKK 425.0M	DKK 425.0M
Noncurrent Recognised Liabilities Defined Benefit Plan	DKK 142.0M	DKK 127.0M	DKK 112.0M
Other Adjustments For Noncash Items	-DKK 127.0M	-DKK 194.0M	—
Other Comprehensive Income	-DKK 245.0M	-DKK 365.0M	—
Other Comprehensive Income Attributable To Owners of Parent	-DKK 98.0M	-DKK 177.0M	—
Other Comprehensive Income Before Tax Cash Flow Hedges	-DKK 23.0M	-DKK 486.0M	—
Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans	DKK 15.0M	DKK 15.0M	—
Other Comprehensive Income Net of Tax Exchange Differences On Translation	-DKK 239.0M	DKK 10.0M	—
Other Current Financial Assets	DKK 890.0M	DKK 591.0M	DKK 1.08B
Other Current Financial Liabilities	DKK 142.0M	DKK 15.0M	DKK 15.0M
Other Current Liabilities	DKK 1.93B	DKK 2.54B	DKK 2.48B
Other Current Nonfinancial Assets	DKK 648.0M	DKK 576.0M	DKK 738.0M
Other Finance Income Cost	DKK 243.0M	-DKK 132.0M	—
Other Inflows Outflows of Cash Classified As Financing Activities	DKK 127.0M	DKK 39.0M	—
Other Longterm Provisions	DKK 299.0M	DKK 373.0M	DKK 269.0M
Other Noncurrent Financial Assets	DKK 2.64B	DKK 2.95B	DKK 4.61B
Other Noncurrent Financial Liabilities	DKK 602.0M	DKK 441.0M	DKK 15.0M
Other Noncurrent Liabilities	DKK 426.0M	DKK 256.0M	DKK 629.0M
Other Noncurrent Nonfinancial Assets	DKK 254.0M	DKK 261.0M	DKK 254.0M
Other Operating Income Expense	-DKK 49.0M	DKK 26.0M	—
Other Reserves	-DKK 10.0M	DKK 96.0M	DKK 278.0M
Other Shortterm Provisions	DKK 485.0M	DKK 514.0M	DKK 582.0M
Payments For Share Issue Costs	DKK 15.0M	DKK 380.0M	—
Proceeds From Changes In Ownership Interests In Subsidiaries	DKK 147.0M	DKK 0	—
Proceeds From Issuing Shares	DKK 4.26B	DKK 3.82B	—
Proceeds From Other Longterm Assets Classified As Investing Activities	-DKK 6.0M	DKK 1.67B	—
Reclassification Adjustments On Cash Flow Hedges Before Tax	-DKK 37.0M	DKK 0	—
Research and Development Expense	DKK 1.39B	DKK 1.44B	—
Retained Earnings	DKK 185.0M	DKK 644.0M	DKK 4.23B
Revenue From Interest	DKK 338.0M	DKK 453.0M	—
Selling General and Administrative Expense	DKK 8.77B	DKK 17.33B	—
Share of Profit Loss of Associates Accounted For Using Equity Method	DKK 16.0M	-DKK 6.0M	—
Trade and Other Current Payables To Related Parties	DKK 213.0M	DKK 1.47B	DKK 1.45B
Trade and Other Current Payables To Trade Suppliers	DKK 1.74B	DKK 1.66B	DKK 1.88B

Methodology

Every line item above is a fact tagged in T&W Medical A/S's annual report filed in the European Single Electronic Format (ESEF) under the IFRS taxonomy (ifrs-full) — the income statement, balance sheet and cash-flow statement as the filer reported them. Values are shown as-is, in the reporting currency (DKK), without rescaling; the row labels map to the underlying concept name (e.g. Revenue → ifrs-full:Revenue, Operating profit → ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS → ifrs-full:DilutedEarningsLossPerShare), and any concept without a curated label is shown under “Other reported items” with its de-camel-cased tag name. Only consolidated, default-member facts are shown (segment / dimensional breakdowns are excluded).

“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.

Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.